ENZON PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Enzon Pharmaceuticals, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2022.
  • Enzon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2022 was $0.000.
  • Enzon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $0.000.
  • Enzon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $0.000.
  • Enzon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $0.000.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-04-26
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-26
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2020-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.